<DOC>
	<DOCNO>NCT00673101</DOCNO>
	<brief_summary>The aim study evaluate liver fibrosis use FibroScan biochemical marker patient treated methotrexate .</brief_summary>
	<brief_title>Prospective Evaluation FibroScan Patients Treated With Methotrexate</brief_title>
	<detailed_description>Methotrexate ( MTX ) effective treatment induction remission maintenance patient Crohn 's disease , rheumatoid arthritis , psoriasis may induce liver fibrosis high cumulative dos . Transient elastography ( FibroScan ) new non-invasive rapid , reproducible bed-side method , allow assessment liver fibrosis measurement liver stiffness . A preliminary study ( Laharie et al , Alimentary Pharmaceutical Therapeutics 2006 ) show significant liver fibrosis rare Crohn 's disease patient treat high dose methotrexate . FibroScan reliable non-invasive method detect liver fibrosis could recommend patient . Therefore , liver biopsy could perform patient high FibroScan value and/or chronic liver enzymes abnormality . However , longitudinal prospective study mandatory confirm preliminary data , patient crohn 's disease also rheumatoid arthritis psoriasis .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Male female subject , â‰¥18 year age . Patient treat Methotrexate . Written informed consent Patients refuse participate study provide write informed consent Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>liver fibrosis , cirrhosis</keyword>
	<keyword>FibroScan</keyword>
	<keyword>transient elastography</keyword>
	<keyword>elastometry</keyword>
	<keyword>methotrexate</keyword>
	<keyword>non invasive blood marker</keyword>
	<keyword>FibroTest</keyword>
	<keyword>treatment</keyword>
</DOC>